Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgan Goetz

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bioengineering & Translational Medicine|July 22, 2024
Vaccine adjuvants for infectious disease in the clinicMorgan Goetz, Naaz Thotathil, Zongmin Zhao, et al.
Trends in Immunology|April 23, 2025
mRNA vaccines: miRNA-based controlled biodistribution and directed adjuvantationByron Brook, Morgan Goetz, Valerie Duval, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 16, 2023
Deep Eutectic Solvents for Subcutaneous Delivery of Protein TherapeuticsAlexander M Curreri, Jayoung Kim, Michael Dunne, et al.
Advanced Materials (Deerfield Beach, Fla.)|October 15, 2020
Ionic-Liquid-Based Safe AdjuvantsAnvay Ukidve, Katharina Cu, Morgan Goetz, et al.
Advanced Healthcare Materials|May 29, 2021
Modulation of Gastrointestinal Mucus Properties with Ionic Liquids for Drug DeliveryKevin Peng, Yongsheng Gao, Pavimol Angsantikul, et al.
Bioengineering & Translational Medicine|May 23, 2022
Use of FLOSEAL® as a scaffold and its impact on induced neural stem cell phenotype, persistence, and efficacyHunter N Bomba, Abigail Carey-Ewend, Kevin T Sheets, et al.
Nature Medicine|April 19, 2019
Author Correction: Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastomaJunfei Zhao, Andrew X Chen, Robyn D Gartrell, et al.
Nature Medicine|February 12, 2019
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastomaJunfei Zhao, Andrew X Chen, Robyn D Gartrell, et al.
Nature Communications|December 3, 2025
Discovery of a small molecule TLR3 agonist adjuvantBranden Lee, Danica Dong, Etsuro Nanishi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bioengineering & Translational Medicine|July 22, 2024
Vaccine adjuvants for infectious disease in the clinicMorgan Goetz, Naaz Thotathil, Zongmin Zhao, et al.
Trends in Immunology|April 23, 2025
mRNA vaccines: miRNA-based controlled biodistribution and directed adjuvantationByron Brook, Morgan Goetz, Valerie Duval, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 16, 2023
Deep Eutectic Solvents for Subcutaneous Delivery of Protein TherapeuticsAlexander M Curreri, Jayoung Kim, Michael Dunne, et al.
Advanced Materials (Deerfield Beach, Fla.)|October 15, 2020
Ionic-Liquid-Based Safe AdjuvantsAnvay Ukidve, Katharina Cu, Morgan Goetz, et al.
Advanced Healthcare Materials|May 29, 2021
Modulation of Gastrointestinal Mucus Properties with Ionic Liquids for Drug DeliveryKevin Peng, Yongsheng Gao, Pavimol Angsantikul, et al.
Bioengineering & Translational Medicine|May 23, 2022
Use of FLOSEAL® as a scaffold and its impact on induced neural stem cell phenotype, persistence, and efficacyHunter N Bomba, Abigail Carey-Ewend, Kevin T Sheets, et al.
Nature Medicine|April 19, 2019
Author Correction: Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastomaJunfei Zhao, Andrew X Chen, Robyn D Gartrell, et al.
Nature Medicine|February 12, 2019
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastomaJunfei Zhao, Andrew X Chen, Robyn D Gartrell, et al.
Nature Communications|December 3, 2025
Discovery of a small molecule TLR3 agonist adjuvantBranden Lee, Danica Dong, Etsuro Nanishi, et al.
Pageof 1